Deze pagina is momenteel niet beschikbaar in uw taal. U kunt met behulp van Google Translate een automatische vertaling bekijken. Wij zijn niet verantwoordelijk voor deze dienstverlening en het vertaalresultaat is niet door ons gecontroleerd.
We are now applying our cutting-edge precision engineering technologies to the challenges of stereotactic neurosurgery
Advanced engineering solutions for stereotactic neurosurgery
Renishaw is applying cutting-edge precision engineering technology to the challenges of functional neurosurgery. We are helping leading clinicians to enhance the safety and cost-effectiveness of their procedures, improving patient outcomes through consistently accurate delivery of implantable devices2/3/4/6/7/8.
Our initial range of products is designed to enable surgeons to implant Deep Brain Stimulation (DBS) electrodes with greater confidence and accuracy relative to targeted brain anatomy. We are also working with a number of medical technology and biotech companies on the development and optimisation of next-generation drug delivery systems for the treatment of serious Central Nervous System diseases.
Meeting tomorrow's demands today
Our solutions are also perfectly aligned with current and emerging therapy technologies such as Deep Brain Stimulation (DBS) and intraparenchymal delivery of next-generation therapeutics. Precision-guided neurosurgery helps clinicians to meet the twin challenges of developing life-enhancing therapies that are both safe and efficient.
These therapies are driving the requirement for ever greater accuracy and reproducibility, improving both individual patient outcome and consistency of such outcome improvement across patient populations. Employing such delivery technologies will thus allow your service to be able to release capacity to expand the number of treatments within existing resources whilst enhancing rather than compromising safety.
Whatever your area of expertise, we have solutions for today that enable you to anticipate the possibilities your vision can bring to your patients tomorrow.